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1. Introduction 
Eating disorders (mainly anorexia and bulimia) affect about 5 million persons each year in 
countries as the United States, and around 3% of young women in western countries have 
an eating disorder (Becker et al., 1991; Sullivan, 1995). Despite these figures, eating disorders 
are still not considered a serious type of mental disorder in some countries, resulting in a 
health care crisis for those currently suffering from these disorders, as well as for their 
families (Klump et al., 2009). Anorexia nervosa is a severe and potentially fatal disease with 
high rate of morbidity and mortality. One review has estimated the aggregate mortality rate 
at 0.56 % per year, or approximately 5.6 % per decade (Sullivan, 1995). At least one third of 
all deaths in patients with anorexia nervosa are estimated to be due to cardiac causes, 
mainly sudden death (Isner et al., 1985; Neumärker, 1997; Sharp & Freeman, 1993). 
Furthermore, the fact that many of these patients are not under medical control leads to the 
risk of potentially fatal complications, sometimes being underestimated . With respect to 
anorexia nervosa, it is an eating disorder characterized by a voluntary restriction of the 
intake, which causes significant weight loss and may reach severe malnutrition and death. 
Most often affects women (estimated ratio of 10:1) aged between 12 and 25 years, the 
adolescence being the time of highest risk. It has not been certain whether mortality rates are 
high for other eating disorders, such as bulimia nervosa and eating disorder not otherwise 
specified, the latter being the most common eating disorder diagnosis (Kaye, 2009). 
Eating disorders are known to result in a variety of potentially serious medical 
complications. These are usually more severe in patients with anorexia nervosa because of 
the complications attendant to starvation but many can also be seen in patients with bulimia 
nervosa, mainly attributed to the purging behaviours in which these patients engage, 
including self-induced vomiting and laxative abuse (Birmingham & Beumont, 2004). 
Cardiovascular complications are common, and they have been reported in up to 80% of the 
cases, mainly in the form of bradycardia, hypotension, arrhythmias, repolarization 
abnormalities and sudden death by up to 10% of the cases (Cooke et al., 1994; De Simone et 
al., 1994; Harris et al., 1993; Isner et al., 1985; Neumärker, 1997; St John Sutton et al., 1985). In 
recent years special attention has been directed to the QT interval electrocardiographic 
abnormalities (Higham & Campbell, 1994; Swenne & Larsson, 1999) and changes in 
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myocardial mass and cardiac function detected in the echocardiographic study (Conri et al., 
1989; Galetta et al., 2002; Lombardi, 1998; Monmeneu et al., 1999).  
Several studies have demonstrated that approximately 30% of deaths in patients with 
anorexia nervosa are due to cardiac complications (Mont et al., 2003). Data indicates that 
80% of patients with an eating disorder have a cardiac complication (Casiero & Frishman, 
2006). In fact, food restriction can lead to increased vagal tone, bradycardia, orthostatic 
hypotension, syncope, arrhythmias, congestive heart failure, and sudden death (Casiero & 
Frishman, 2006). In addition, mitral valve prolapse has been shown in more than 30% of 
patients with eating disorders compared to 4% of controls (Johson et al., 1986). Among 
eating disorder patients, cardiac complications are most common in those with laxative 
and/or diuretic abuse, and data indicate that, at least at the early stages, cardiac 
abnormalities are reversible with weight restoration (Mont et al., 2003). 
 Cardiovascular complications for patients with bulimia nervosa can include arrhythmias, 
palpitations, orthostatic hypotension, and electrocardiographic disturbances, which may be 
due to electrolyte imbalances (Katzman et al., 2011; Rome & Ammerman, 2003; Walsh et al., 
2000).  Patients who engage in self-induced vomiting or diuretic or laxative abuse may also 
become dehydrated, which can result in dizziness and fainting (Pomeroy & Mitchell, 2002). 
The abuse of emetics as Ipecac can result in irreversible and potentially fatal 
cardiomyopathies (Halmi, 2002). 
2. QT abnormalities and bradycardia 
The QT interval is a measure of the time between the start of the QRS complex and the end 
of the T wave in the heart's electrical cycle. In general, the QT interval represents electrical 
depolarisation and repolarisation of the left and right ventricles. The duration of the QT 
interval of the electrocardiogram is a function of the heart rate, and a prolonged QT interval 
is a biomarker for ventricular tachyarrhythmia and a risk factor for sudden death. 
Summarizing, the QT interval is a measure of myocardial repolarisation and its length is 
associated with life threatening ventricular tachycardia (Cooke et al., 1994). The Bazett rate 
correction formula is commonly used to correct the QT interval for heart rate (QTc). The 
Bazett formula is convenient and easy to use, but an approximation that may miss or 
exaggerate abnormalities (Browne et al., 1982). The most commonly used cut-off point for 
QTc is 440 ms (Vázquez et al., 2003). Figure 1 shows a case of sinus bradycardia. 
 
Fig. 1. Sinus bradycardia 
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With regards to eating disorder patients, QT interval abnormalities have been studied as a 
marker of sudden death and to assess the effect of refeeding. In fact, it has been proposed 
that these deaths are a result of cardiac arrhythmias for which a long QT interval on the 
electrocardiogram is a marker (Isner et al., 1985). Nevertheless, the measurement of the QT 
interval has a poor predictive value for the recognition of patients who are at particular risk 
of sudden death. A measured QT interval >600 ms is associated with a significant risk of 
sudden death (Jackmann et al., 1988), but few patients usually have such long QT intervals. 
Another QT parameter is the QT dispersion (QTd), which is the difference between the 
maximum QT and the minimum QT in all derivations. Finally, the dispersion of the 
corrected QT interval (QTcd) is the difference between the maximum and the minimum QTc 
interval in the 12 electrocardiographic derivations. The most used cut-off point for the 
dispersion is 60 ms (Bayés de Luna & Viñolas, 1996; Girola et al., 2001; Hill & Friedman, 
1997; Lund et al., 2002; Toivonen, 2002).  
Considering the main studies on the QT interval among patients with anorexia nervosa, 
there are some controversial results. Thus, some studies have not found long QT intervals 
(Powers et al., 1991; Gottdiener et al., 1978) while others have found long QT intervals 
(Cooke et al., 1994; Isner et al., 1985; Thurston & Marks, 1974). Apart from methodological 
problems, these conflicting results could be explained by difficulties in comparison due to 
the huge variability of the QT interval with heart rate (Cooke et al., 1994). In a recent study, 
QT and QTc intervals as well as the dispersion intervals QTd and QTcd were longer among 
anorectic women than in a control group (Vázquez et al., 2003). 
In relation with the undernutrition state of anorexia nervosa, arrhythmias, especially 
bradycardia, are the best-known cardiac disturbances probably as a response to maintain 
body energy by means of a decrease of cardiac work. There have been different proposed 
pathogenic mechanisms to explain those disturbances: electrolyte loss, drugs adverse 
cardiovascular effects, decreased glycogen content in the cardiac cell, myofibril atrophy, 
interstitial oedema, mitochondrial swelling, and activation of calcium-dependent 
proteinases.  With respect to the pathological basis of a long QT interval in anorexia nervosa 
there are some proposals too: cardiac muscle is lost in proportion to loss of body mass, but 
there is no convincing evidence of impairment of ventricular function in these patients, 
histological studies have not shown myocarditis, abnormalities of the hypothalamus are 
well described and, finally, a increased autonomic tone has been suggested as a possible 
mechanism for lengthening the QT interval (Clark & Wildenthal, 1986; Thurston & Marks, 
1974; Palossy & Oó, 1977; Powers et al., 1991; Tolnay & von Althen, 1987).  
In general, the most frequent findings among anorectic patients have been arrhythmias, 
bradycardia, atrial extrasystoles, isolated premature ventricular contractions and a 
significant increase QT and QTc, compared with healthy women of similar age 
(Panagiotopoulos et al., 2000; Swenne & Larsson, 1999; Vázquez et al., 2003). As a result of 
these findings, some authors have suggested that weight loss in patients with anorexia 
nervosa and eating disorders in general is a risk factor for the prolongation and dispersion 
of the QT interval (Galetta et al., 2002; Swenne & Larsson, 1999). In fact, a significant and 
negative correlation between QTc and body mass index has been reported (Vázquez et al., 
2003). An increase of the QT interval dispersion represents regional differences in 
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myocardial excitability recovery and may lead to and increased arrhythmogenic substrate, 
with a higher risk for ventricular arrhythmias clinically significant and a higher risk of 
sudden death. In fact, the increased QT interval and the increased QT dispersion have been 
associated with higher risk of ventricular arrhythmias in both patients with heart disease 
and healthy individuals. Thus, the predictive value of the increased QT interval dispersion 
as a marker of sudden acute ventricular arrhythmia or death has been demonstrated (Harris 
et al., 1993; Isner et al., 1985). Recently, parameters of QT variability have been proposed as 
surrogate markers for arrhythmia risk stratification in anorexia nervosa (Koschke et al., 
2010). A meta-analysis of heart rate and QT interval alteration in anorexia nervosa showed 
that bradycardia and relationship between heart rate and body mass index decreases as the 
disease continues. Moreover QTc interval in anorectic patients was within normal range 
although significantly longer than in controls (Lesinskiene, et al., 2008).  
Considering the subtypes of anorexia nervosa, a significant increase has been found in 
weight/height ratio and body mass index from malnourished stage to weight restoration, 
paralleled by a significant decrease in QTd among anorectic patients (restricting type) 
(Nahshoni, et al., 2007). With respect to bulimia nervosa, compared with the controls, 
bulimic patients with a history of anorexia nervosa seem to have significantly more signal-
averaged electrocardiography abnormalities (Takimoto et al., 2006). Besides the relationship 
between QT changes and potential fatal arrhythmias, those changes have shown to be 
related with low resting metabolic rate among chronic anorectic patients (Krantz et al., 
2005). Despite the fact that the majority of studies have highlighted the QT disturbances in 
anorexia nervosa, a prolonged QT interval and QT dispersion have been reported in both 
anorexia nervosa and bulimia nervosa (Takimoto et al., 2004). In fact, QT and QTd have 
been shown to be significantly longer in all eating disorder subtypes than in controls. 
Moreover, QT interval and QTd were significantly correlated with the rate of body weight loss 
in bulimia nervosa (Takimoto et al., 2004). Figure 2 shows a long QT related to weight loss. 
 
Fig. 2. Long QT interval 
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2.1 QT abnormalities and refeeding 
The effect of the reached target weights on QT interval has been demonstrated, with a 
significant shortening of that interval by means of an adequate refeeding (Cooke et al., 
1994). After admission, the QT prolongation and dispersion are usually normalized within 
the 3 days of refeeding (Swenne, 2000). After refeeding, a significant decrease in QT interval 
and QT dispersion has been observed as well as a normalization of the heart rate and heart 
rate variability (Mont et al., 2003). On the other hand, the QT/RR slope has been found 
significantly enhanced in anorectic patients compared with healthy controls, and this slope 
returns to normal range values after refeeding. This QT/RR slope seems to be significantly 
correlated with the body mass index in the patient group (Roche et al., 2005). During the 
follow-up of these cardiac abnormalities in female adolescents with anorexia nervosa, one 
year after refeeding a significant decrease in QT, QTc, QTd and QTcd has been reported 
(Ulger et al., 2006). 
3. Structural changes 
With respect to the cardiac structural changes in eating disorders those referred to the 
interventricular septum and the left ventricular mass have been the most studied ones. With 
regards to anorexia nervosa, echocardiography has shown a reduction in the dimensions of 
the interventricular septum (52% of patients), left ventricular free wall (61%), left atrium 
(31%) and left ventricular mass (61%) (Silvetti et al., 1998). More recently, by means of tissue 
Doppler imaging, when compared with control groups, anorectic patients have shown 
lower left ventricular mass, lower myocardial systolic wave peak of both lateral wall and 
septum, and comparable early (Em) and atrial (Am) diastolic waves, and Em/Am ratio. On 
the other hand, the ratio between transmitral peak E-wave and Em has shown significantly 
greater in anorectic patients than in controls, while no differences have been observed 
between thin and normal-weight females. In anorectic patients, Sm peak has been 
significantly related to left ventricular mass indexed, at both septum and lateral wall levels 
(Galetta et al., 2005). Anorexia nervosa has been associated with a significant reduction in 
the cyclic variation in the integrated backscatter (IBS) signal of the myocardium, which is 
also related to left ventricular hypotrophy (Franzoni et al., 2003). 
With respect to the ventricular mass, left ventricular chamber dimension and mass seem to 
be significantly less in women with anorexia nervosa than in either the women of normal 
weight or the thin women, even after standardisation for body size or after controlling for 
blood pressure. Nevertheless it seems that there are no substantial changes in the left 
ventricular shape (De Simone et al., 1994). Some authors have reported a high frequency of 
mitral valve prolapse due to the disproportion between ventricle and valve among anorectic 
patients (Conri et al., 1989).  
3.1 Structural changes and refeeding 
Other studies have highlighted that the left ventricular mass index is significantly lower 
than that in normal subjects as well as the left ventricular end-diastolic and end-systolic 
volume indexes. Nevertheless, in spite of the reductions in left ventricular mass and volume 
indexes, left ventricular chamber architecture described as h/R ratio, mass to volume ratio, 
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and short/long left ventricular axis ratio usually is normal. The same applies to the left 
ventricular afterload assessed as end-systolic meridional and circumferential wall stress. 
Moreover, among anorectic patients, ejection fraction, percent fractional shortening, and the 
relationship between end-systolic wall stress and ejection fraction have been all within 
normal limits. In some patients restudied after a 15% to 20% weight gain, left ventricular 
mass and volume indexes increased significantly but end-systolic wall stress and ejection 
fraction did not change (St John Sutton et al., 1985).  
 
Fig. 3. Mitral valve prolapse 
Control echocardiograms of anorectic patients after refeeding have shown an increase in left 
ventricular diameters and cardiac mass (Ulger et al., 2006). Apart from that, 
echocardiograms have shown an increase in cardiac output, an improvement in the exercise 
capacity, and a normalization of the heart rate and heart rate variability after refeeding 
(Mont et al., 2003). Other authors have reported that cardiac complications of anorexia 
nervosa are common, usually benign and always reversible after refeeding in hospital 
(Lupoglazoff et al., 2001). Figure 3 shows a mitral valve prolapse.  
4. Left ventricular function 
In a pioneer study (Gottdiener et al., 1978), the authors found that in spite of the structural 
changes, left ventricular systolic function, was unimpaired as indicated by normal 
echocardiographic fractional shortening, and by normal exercise augmentation of ejection 
fraction determined by radionuclide cineangiography. Another study showed that there 
was no evidence of arrhythmias at rest, during exercise, or with continuous 
electrocardiographic recording, concluding that young patients with anorexia nervosa 
appeared to have essentially normal cardiac function with a reduction in left ventricular 
muscle mass (Moodie & Salcedo, 1983). It seems that the down-regulation of left ventricular 
mass per se, like up-regulation of left ventricular mass, is not associated with abnormal left 
ventricular function (St John Sutton et al., 1985). Other authors have reported similar results 
(Dec et al., 1987) and a cardiovascular vagal hyperactivity in anorectic patients, which 
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appears to influence the ventricular diastolic dynamics. Heart rate variability and diastolic 
function analysis have been proposed as useful tools in monitoring anorexia-induced 
cardiac modifications (Galetta et al., 2003). 
Apart from bradycardia, hypotension, tachycardia, a decrease in cardiac chamber size, 
impaired left ventricular contractility, electrocardiographic changes, pericardial effusion, 
and mitral valve prolapse, in patients with anorexia nervosa, some previous articles, as the 
above-mentioned ones have focused on the effects of anorexia nervosa on left ventricular 
function. However, atrial function in patients with anorexia nervosa has not been studied. 
The percentage of total transmitral flow contributed by atrial contraction is about 30% (Jovic 
& Troskot, 1977), which indicates the importance of atrial function in left ventricular filling, 
and a case of anorexia nervosa as cause of atrial failure has been described (Mizuno et al., 
1998). 
Cardiac disturbances in anorectic patients are essentially derived from malnutrition and 
starvation. On a cellular level this leads to diminish the protein synthesis, activation of 
calcium-dependent proteinases, mitochondrial swelling, decreased glycogen content, 
interstitial oedema, and myofibrillar atrophy. The physiologic consequences of the 
malnutrition include decreased contractile force of the ventricle, decreased cardiac output, 
and decreased diastolic compliance. Clinically, bradycardia, relative hypotension, mitral 
valve prolapse, and diminished exercise capacity may all be seen in these patients as well as 
the above mentioned atrial dysfunction (Abel et al., 1979; Fohlin, 1977; Goldberg et al., 1988; 
Gottdiener et al., 1978; Johnson et al., 1986; Meyers et al., 1986; Monmeneu et al., 1999; 
Moodie, 1987; Nutter et al., 1979; Tolnai & von Althen, 1987; Warren & Vande Wiele, 1973). 
5. Electrolyte changes 
Eating disorder patients may show varying degrees of dehydration, sodium and chloride 
depletion, mainly in patients who vomit, potassium deficiency in patients with laxatives 
abuse, and weaknesses of chlorine, sodium and potassium in patients using diuretics, with 
different depletions depending on the substance used. With respect to electrolyte 
disturbances, typical laboratory changes, although not exclusively seen in anorexia nervosa, 
include hyponatremia, hypokalaemia, and hypochloremia (Baumann et al., 2010).  
The presence of the symptoms listed below usually indicates a water loss of about 25% (or 
more) and indicates a severe situation: oliguria, sunken eyes, dry mucous membranes (dry 
mouth), shrivelled skin, fever and muscle cramps. Along with this, blood parameters will 
show an increase of haematocrit value, and increase of the total proteins, increased urine 
density, and increased urea concentration in urine. 
Considering hypochloremia, it would be moderate with a level within a range between 90-
95 mEq/L, more severe between 80-90 mEq/L and severe (which would require urgent 
treatment) an amount of chlorine in blood below 80 mEq/L. The hypochloremia key signs 
are hypotension and paresis or intestinal ileus.  
Hyponatremia is considered moderate when blood sodium levels between 130 and 138 
mEq/L, severe with levels between 125 and 130 mEq/L, and very severe when the sodium 
level is below 125 mEq/L. The characteristic signs are: muscle contractures, muscle aches, 
muscle fibrillations and sometimes seizures. Hypotension is less common than in 
hypochloremia, but usual. The accepted normal range is 135-145 mEq/L. 
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With respect to hypokalaemia, it is moderate between 3-3.5 mEq/L, severe between 2.5 and 
3 mEq/L and very severe when less than 2.5 mEq/L. Clinically, there is an hypotonic 
smooth and striated fibres resulting in severe fatigue, loss of muscle strength and sometimes 
paralysis. There is frequently hypo- or arreflexia and intestinal paresis, but the worst 
complication refers to the involvement of the heart muscle. Repolarization abnormalities 
(prolonged and depressed QT interval, and decreased height of the T wave) are usually 
found. Nevertheless there is no correlation between potassium levels and specific signs in 
the ECG. In any case, cardiac or respiratory arrest is the most frequent cause of sudden 
death.  The accepted normal range is 3.4-4.8 mEq/L. The following are the main 
electrocardiographic changes considering different levels of plasma potassium: 
 T-wave flattening or T-wave inversion (Potassium: 3-3.8 mEq/L). 
 Long QT interval, prominent U-wave, depression of the ST segment, ventricular 
extrasystoles (Potassium: 2.3-3 mEq/L). 
 Torsades de pointes, ventricular fibrillation (Potassium: < 2.3 mEq/L). 
 
Fig. 4. Ventricular fibrillation 
Hypocalcaemia is not frequent among eating disorder patients, hypophosphatemia being 
more common, especially during refeeding. During refeeding, redistribution from the 
extracellular to the intracellular space by increasing insulin secretion is found. Another 
possible, but infrequent finding, is hypoglycaemia. Long restrictive periods lead to the 
exhaustion of carbohydrates from the last meal, as well as those stored as glycogen. In these 
situations a syndrome with anxiety, palpitations, sweating, pallor and tachycardia is usual. 
Many times, this syndrome is labelled as "anxiety attacks" and therefore poorly addressed 
(Rotellar, 1973; Jáuregui, 2006). 
In a cross-sectional, community-based study (Miller et al., 2005) in women with anorexia 
nervosa, the lowest value for plasma sodium was 122 mEq/L, and 7% of participants had 
hyponatremia. One participant reported a history of seizures secondary to hyponatremia 
and none had hypernatremia. The lowest value for plasma potassium was 1.9 mEq/L, and 
20% of participants had hypokalaemia, including the 6 women who reported taking 
potassium supplements. Of the participants with low potassium levels, 48% reported that 
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they regularly purged, whereas the remainder (52%) denied purging. In a previous large 
study in an outpatient treatment program has reported the absence of hypokalaemia in non-
purgers anorectic patients (Rieger et al., 1978). Mean plasma potassium level was lower for 
the women who reported purging than for those who did not (3.5 vs. 3.7 mEq/L). A history 
of dysrhythmia was reported by 2% of the women and, in most cases, hypokalaemia was 
noted as the probable. Serum calcium levels were low in 6% of participants. 
The reported serious cardiac abnormalities in patients with anorexia nervosa include 
dysrhythmias, some of which may be secondary to hypokalaemia (Sharp & Freeman, 1993; 
Bonne et al., 1993).  Screening and monitoring patients with anorexia nervosa for cardiac 
risk factors and dysfunction is important, and this should include asking patients whether 
they purge or have histories of hypokalaemia and/or purging behaviours. Monitoring vital 
signs and performing electrocardiograms and serial measurements of plasma potassium are 
also important. This is important, as purging may increase the risk of hypokalaemia and 
subsequent cardiac dysrhythmias, and self-induced vomiting increases the risk of additional 
complications (Miller et al., 2005). In fact, QT prolongation and ventricular arrhythmia may 
develop in the setting of severe hypokalaemia, exposing patients to high risk of sudden 
cardiac event (Facchini et al., 2006). 
6. Purging behaviours and effects of drugs (laxatives, diuretics, stimulants) 
Some studies (e.g., Facchini et al., 2006) have found hypokalaemia only in anorectic patients 
who vomited. In these patients, serum chloride values were also low. With respect to the 
causes of this hypokalaemia, anorectic patients who vomit lose hydrogen, chloride and 
water and develop that hypokalaemia not only because of shift of potassium ion into cells as 
the result of alkalosis, but also because of increased potassium ion excretion in the urine as 
the result of reabsorption of hydrogen ion. Moreover, secondary aldosteronism due to the 
decrease of total body water also causes increase of potassium ion excretion in the urine. 
Finally, frequent vomiting causes hypokalaemia, which sometimes results in arrhythmia or 
heart arrest (Koh et al., 1989). Purging behaviours have been related to electrolyte 
disturbances and, consequently, associated with cardiac disturbances (Fohlin, 1977; Halmi, 
1983; Mars et al., 1982; Rajs et al., 1986). In Figure 5, a case presenting hypokalaemia, long 
QT and torsades de pointes, is shown. 
Generally, individuals who abuse laxatives may be constipated patients, people engaged in 
athletic training and eating disorder patients, the latter being the most relevant group. The 
most frequently abused group of laxatives are of the stimulant class. This may be related to the 
quick action of stimulants, particularly in individuals with eating disorders, as they may 
erroneously believe that they can avoid the absorption of calories via the resulting diarrhoea. 
Medical problems associated with laxative abuse include electrolyte and acid/base changes 
that can involve the renal and cardiovascular systems and may become life threatening. The 
renin-aldosterone system becomes activated due to the loss of fluid, which leads to oedema 
and acute weight gain when the laxative is discontinued. This can result in reinforcing further 
laxative abuse when a patient feels bloated and has gained weight (Roerig et al., 2010)).  
With respect to substance use, a recent study has shown that, in general, eating disorders 
were associated with greater substance use relative to the control group. Considering the 
stimulants, across groups, statistically significant differences emerged, the anorectic patients 
group being more likely to use stimulants (more than 10 times per month) relative to the 
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referent. Those in the anorectic and bulimic groups were more likely to use stimulants (life 
time use) compared to the control group (Root et al., 2010).  
 
 
Fig. 5. Hypokalaemia: Long QT interval and torsades de pointes. 
 
Fig. 6. Prominent U-wave (usual finding in hypokalaemia) 
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In a pioneer study (Ong et al., 1983), eight patients with bulimia nervosa were given 
methylamphetamine or placebo intravenously under double blind controlled conditions. In 
every patient, methylamphetamine reduced self-ratings of hunger and amount of food eaten 
as measured under laboratory conditions. This finding showed that experimental drugs 
could modify the food intake of bulimic patients. Although weight loss is among the most 
commonly cited reasons for using methamphetamine, little is known about the association 
between eating disorders and treatment outcomes in the population of methamphetamine 
dependent patients. In a recent study, bulimia nervosa was observed among 2.4% of the 
participants (methamphetamine dependent adults) (Glasner-Edwards et al., 2011). Apart 
from weight loss, methamphetamine is frequently used as a recreational drug because of its 
stimulant effects. Recent studies suggest that methamphetamine use is present in at least 5% 
of all patients presenting to the emergency room with heart failure and 40% of patients 
under the age of 45 admitted to the hospital with cardiomyopathy. Chronic use has also 
been associated with the development of chronic coronary disease as well as 
cardiomyopathy (Diercks et al., 2008;Karch et al., 1999; Turnipseed et al., 2003; Wijetunga et 
al., 2004; Yeo et al., 2007). 
 
Fig. 7. Stimulants-induced sinus tachycardia 
Despite that recovery of left ventricular dysfunction in patients with methamphetamine-
induced cardiomyopathy has been described, since the effects of methamphetamine can 
include myocyte hypertrophy and fibrosis, both relatively irreversible processes, it is likely 
that some patients will not recover left ventricular function with either appropriate medical 
therapy or abstinence from methamphetamine (Lopez et al., 2009). 
Besides self-inducing vomiting and abuse laxatives, misusing diuretics is the other main 
cause of hypokalaemia among purging-type eating disorder patients (Greenfeld et al., 1995). 
Prevalence of hypokalaemia between 4.6-20% of eating disorder patients who purge or 
abuse diuretics has been reported, and diuretics and laxatives are the most commonly 
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abused purging medications by patients with purging-type eating disorders. In a former 
study (Mitchell et al., 1985) among bulimic patients, 33.9 % of diuretic abuse and 60.6% of 
laxative abuse was found, and may be that these figures underestimate the prevalence of 
diuretic abuse due to the fact that such medication is not only obtained by prescription but 
is also available in many over-the-counter formulations (92). Again the risk for 
cardiovascular disturbances is present by means of the relationship between diuretic abuse 
and hypokalaemia (Mascolo et al., 2011). 
7. The heart response facing a higher metabolic demand (refeeding 
syndrome) 
Refeeding syndrome has been considered one of the most serious complications related to 
anorexia nervosa, one which can occur, and possibly prove fatal, with oral as well as enteral 
and parenteral feeding. The syndrome involves a set of alterations caused by too rapid or 
unbalanced refeeding in a severely malnourished patient. The main signs and symptoms 
include sodium and water retention (leading to oedema and possible cardiac failure), 
hypophosphatemia due to intracellular disturbances (causing generalised systemic 
problems and a difficulty with energy storage), and the depletion of electrolytes, such as 
potassium and magnesium, as well as of vitamins (with the associated clinical 
consequences) and thiamine cofactor, which can lead to Wernicke’s syndrome and/or 
cardiomyopathy. The calorie intake with which the syndrome may occur varies widely 
among the reported cases (between 10 and 60 kcal/kg/day), while the presence of glucose 
in the alimentary canal of extremely malnourished patients is a determining factor that can 
trigger the process (Katzman, 2005; Marinella, 2005; Miller, 2008; O’Connor & Goldin, 2011; 
Solomon, 1990; Tey et al., 2005). 
Refeeding syndrome must be prevented and, therefore, many studies have sought to 
establish guidelines for medical and nursing care. The recommendations are to achieve a 
weight gain of approximately 500 g/week and constantly monitor fluid intake. 
Administration of phosphorus and potassium may be beneficial during the initial weeks of 
refeeding and the potential value of high-calorie supplements should also be assessed. At all 
events, the calorie intake should be carefully matched to the initial baseline metabolic rate 7, 
as should the carbohydrate intake (De Cock et al., 2006; Hearing, 2004; Portsmouth 
Hospitals NHS Trust, 2007). 
Refeeding syndrome consists of cardiovascular, neurologic, and hematologic complications, 
and can be associated with significant morbidity and mortality. Adverse effects of 
hypophosphatemia include cardiac failure, muscle weakness, immune dysfunction, and 
death. Cardiac sequelae are secondary to and occur early in the cascade of events that arise 
during refeeding. Congestive heart failure results from the decreased ventricular mass and 
myofibrillar atrophy, causing decreased stroke volume and reduced capacity of the 
cardiovascular system (Katzman, 2005). 
Kohn et al. described acute cardiac complications (arrhythmias, bradycardia, pericardial 
effusion, hypotension, and cardiac arrest) in anorectic patients during refeeding. These 
patients developed life-threatening complications associated with refeeding including 
cardiac arrhythmias documented within the first week of hospitalization.  
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8. Blood pressure changes 
Besides de above-mentioned cardiovascular disturbances of eating disorders, another 
common complication is orthostatic hypotension. Orthostatic heart rate and blood pressure 
changes are common in anorectic patients on admission to hospital (Shamim et al., 2003). 
These orthostatic changes place patients with anorexia nervosa at increased risk of syncope. 
One explanation for the observed orthostatic changes is that starvation leading to low body 
weight may result in atrophic peripheral muscles, resulting in decreased venous return to 
the heart. 
Recent evidence has shown that normalization of orthostatic pulse changes occurs after 
approximately 3 weeks of nutritional rehabilitation when patients reach 80% of their ideal 
body weight. It has been suggested that the resolution of orthostasis can be used as an 
objective measure of medical stability in patients with anorexia nervosa (Shamim et al., 
2003). 
9. Conclusions 
Eating disorders, particularly anorexia nervosa, are life-threatening diseases, with high risk 
of death due to cardiovascular disturbances. Cardiovascular complications are present 
promptly, mainly in cases of anorexia nervosa, with more or less severity with regards to 
structural and functional changes. Cardiovascular complications in eating disorder include 
bradycardia, QT interval prolongation, orthostatic hypotension, increased vagal tone, mitral 
valve prolapse (as a consequence of weight loss with an associated reduction in left ventricle 
mass, resulting in a relatively large mitral valve), possible alterations in myocardial 
contractility, and reduction in left ventricular wall thickness, among others.   
The severity of the eating disorders, specifically the undernourished state, is usually 
significantly correlated with increased bradycardia and decreased left ventricular force. In 
this regard, patients with severe sinus bradycardia should be admitted to the hospital in 
order to monitoring the cardiac function and to gain weight gradually.  
Despite the conflicting results about the QT interval alterations, the prolongation of the QT 
is usually associated with sudden ventricular arrhythmias and death.   
Eating disorders may show cardiac abnormalities depending on electrolyte changes 
associated with purging behaviours and/or drug effects, among other causes.  
Orthostatic heart rate and blood pressure changes are common in patients with eating 
disorders, mainly in cases of anorexia nervosa, and it has been suggested that the resolution 
of orthostatism could be an objective measure of medical stability.  
The main cardiovascular findings among patients with eating disorders are reversible by 
means of an appropriate refeeding. As a result of this refeeding an increase in cardiac 
dimensions, ventricular mass, and cardiac output are reached.  
Cardiovascular complications in eating disorders may be potentially fatal and they are 
usually present in early stages of these diseases, being in most cases reversible. An early 
diagnostic, a prompt treatment, a correct refeeding, and the cardiac monitoring of all 
patients, are necessary. 
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10. Summarizing  
 Cardiovascular complications of eating disorders are common, and they have been 
reported in up to 80% of the cases, mainly in the form of bradycardia, hypotension, 
arrhythmias, repolarization abnormalities and sudden death by up to 10% of the cases. 
 Despite the conflicting results with respect to QT interval in anorexia nervosa, recent 
studies show that QT and QTc intervals as well as the dispersion intervals QTd and 
QTcd are longer among anorectic patients than in controls. 
 With respect to bulimia nervosa, bulimic patients with a history of anorexia nervosa 
seem to have significantly more signal-averaged electrocardiography abnormalities 
than controls. 
 During hospitalization the QT prolongation and dispersion usually normalize within 
the three days of refeeding. 
 The most described structural changes in anorexia nervosa have been the reduction in 
the dimensions of the interventricular septum, left ventricular free wall, left atrium and 
left ventricular mass. 
 Control echocardiograms of anorectic patients have shown an increase in cardiac 
output, an improvement in the exercise capacity, and a normalization of the heart rate 
and heart rate variability after refeeding. 
 In spite of the structural changes, left ventricular systolic function usually keeps 
unimpaired. 
 Considering the electrolyte changes, typical laboratory findings in eating disorders 
include hyponatremia, hypokalaemia and hypochloremia. 
 Purging behaviours may increase the risk of hypokalaemia and subsequent cardiac 
dysrhythmias. Thus, monitoring vital signs and performing electrocardiograms and 
serial measurements of plasma potassium are relevant. 
 Medical problems associated with laxative abuse include electrolyte and acid/base 
changes that can involve the renal and cardiovascular systems and may become life 
threatening. 
 The chronic use of methamphetamine has been associated with the development of 
chronic coronary disease as well as cardiomyopathy. 
 During refeeding, adverse effects of hypophosphatemia include cardiac failure among 
others. Cardiac sequelae are secondary to and occur early in the cascade of events that 
arise during refeeding. 
 Orthostatic changes place patients with anorexia nervosa at increased risk of syncope. 
The normalization of orthostatic pulse changes occurs approximately after three weeks 
of nutritional rehabilitation when patients reach 80% of their ideal body weight. 
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